PERCEPTIVE ADVISORS LLC Q2 2020 Filing

Filed August 14, 2020

Portfolio Value

$6.2T

Holdings

124

Report Date

Q2 2020

Filing Type

13F-HR

All Holdings (124 positions)

#StockSharesValue% PortfolioType
101
ATECALPHATEC HLDGS INC
561,574$2.6B0.04%
102
GRTXGALERA THERAPEUTICS INC
325,000$2.3B0.04%
103
PHRPHREESIA INC
70,000$2.0B0.03%
104
MDTMEDTRONIC PLC
20,000$1.8B0.03%
105
RVNCEURREVANCE THERAPEUTICS INC
65,839$1.6B0.03%
106
DVAXDYNAVAX TECHNOLOGIES CORP
176,950$1.6B0.03%
107
CLDNEUREIGER BIOPHARMACEUTICALS INC
139,890$1.3B0.02%
108
LEGNLEGEND BIOTECH CORP
25,000$1.1B0.02%
109
RACEFERRARI N.V
6,200$1.1B0.02%
110
LVGOLIVONGO HEALTH INC
13,620$1.0B0.02%
111
MOMENTA PHARMACEUTICALS INC
30,637$1.0B0.02%
112
TREURTRILLIUM THERAPEUTICS INC
114,674$928.0M0.02%
113
SIERRA ONCOLOGY INC
66,655$807.0M0.01%
114
KRTXKARUNA THERAPEUTICS INC
6,944$774.0M0.01%
115
AKBAAKEBIA THERAPEUTICS INC
52,724$716.0M0.01%
116
KRMDREPRO MED SYS INC
74,813$672.0M0.01%
117
CUECUE BIOPHARMA INC
26,371$646.0M0.01%
118
LUMINEX CORP DEL
18,926$616.0M0.01%
119
CCXIEURCHEMOCENTRYX INC
10,252$590.0M0.01%
120
TGTXTG THERAPEUTICS INC
29,762$580.0M0.01%
121
VIRVIR BIOTECHNOLOGY INC
13,024$534.0M0.01%
122
APLSAPELLIS PHARMACEUTICALS INC
11,418$373.0M0.01%
123
AVDLAVADEL PHARMACEUTICALS PLC
8,681$133.0M0.00%
124
OUTLOOK THERAPEUTICS INC
420,875$108.0M0.00%
PreviousPage 2 of 2